ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

Raub Corrects Record on ALERT

April 20, 1984

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002